This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brathwaite, O. Articles by Newcomb, E. W. Search for Related Content PubMed PubMed Citation Articles by Brathwaite, O. Articles by Newcomb, E. W.

p53 Mutations in C57BL/6J Murine Thymic Lymphomas Induced by -Irradiation and N-Methylnitrosourea¹

New York University and Kaplan Comprehensive Cancer Center, New York, New York 10016

Genomic DNA from thymus tissue obtained from 47 C57BL/6J animals treated with the DNA alkylating agent N-methylnitrosourea or -irradiation were screened for the presence of p53 mutations by using the single strand conformation polymorphism assay. Mutations were detected in 13% (4 of 30) of primary thymic lymphomas but none of 17 early stage lymphomas. The frequency of p53 mutations was the same in tumors induced by N-methylnitrosourea (2 of 15) or by -irradiation (2 of 15). Mutations occurred in the highly conserved regions of the p53 gene in exons 5, 7, and 8. G:C to A:T transitions were commonly observed. One of 4 of the tumors analyzed contained two p53 mutations in exons 7 and 8. A previous study of the same tumors showed that ras mutations occurred with high frequency (>50%) (E. W. Newcomb et al., Cancer Res., 48: 5514–5521, 1988). Our data suggest that p53 mutations do not play a major role in carcinogen-induced thymic lymphomas studied here.

¹ This work was supported by National Cancer Institute Grant CA 40533.

² To whom requests for reprints should be addressed, at Department of Pathology and Kaplan Comprehensive Cancer Center, New York University Medical Center, 550 First Avenue, New York, NY 10016.

Received 3/16/92. Accepted 5/13/92.

This article has been cited by other articles:

				M.M. de Yzaguirre, J.S. Hernandez, P.F. Navarro, P.L. Nieva, M. Herranz, M.F. Fraga, M. Esteller, A. Juarranz, and J. Fernandez-Piqueras Epigenetic silencing of E- and N-cadherins in the stroma of mouse thymic lymphomas Carcinogenesis, May 1, 2006; 27(5): 1081 - 1089. [Abstract] [Full Text] [PDF]

				P. Lopez-Nieva, J. Santos, and J. Fernandez-Piqueras Defective expression of Notch1 and Notch2 in connection to alterations of c-Myc and Ikaros in {gamma}-radiation-induced mouse thymic lymphomas Carcinogenesis, July 1, 2004; 25(7): 1299 - 1304. [Abstract] [Full Text] [PDF]

				T. Portis, W. J. Grossman, J. C. Harding, J. L. Hess, and L. Ratner Analysis of p53 Inactivation in a Human T-Cell Leukemia Virus Type 1 Tax Transgenic Mouse Model J. Virol., March 1, 2001; 75(5): 2185 - 2193. [Abstract] [Full Text]

				C. J. Kemp, S. Sun, and K. E. Gurley p53 Induction and Apoptosis in Response to Radio- and Chemotherapy in Vivo Is Tumor-Type-dependent Cancer Res., January 1, 2001; 61(1): 327 - 332. [Abstract] [Full Text]

				M. Yamamoto, T. Tsukamoto, H. Sakai, N. Shirai, H. Ohgaki, C. Furihata, L. A. Donehower, K. Yoshida, and M. Tatematsu p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis Carcinogenesis, October 1, 2000; 21(10): 1891 - 1897. [Abstract] [Full Text] [PDF]

				B. Melendez, M. Malumbres, I. P. de Castro, J. Santos, A. Pellicer, and J. Fernandez-Piqueras Characterization of the murine p19ARF promoter CpG island and its methylation pattern in primary lymphomas Carcinogenesis, April 1, 2000; 21(4): 817 - 821. [Abstract] [Full Text] [PDF]

				I. P. de Castro, M. Malumbres, J. Santos, A. Pellicer, and J. Fernandez-Piqueras Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas Carcinogenesis, September 1, 1999; 20(9): 1675 - 1682. [Abstract] [Full Text] [PDF]